Related Experiment Video
Updated: May 23, 2026

12:06
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
Host stem cells repopulate liver allografts: reverse chimerism
Zhaoli Sun1, George Melville Williams
1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. zsun2@jhmi.edu
Chimerism
|April 18, 2012
Summary
Achieving transplant tolerance after liver transplantation is possible. Manipulating the immune response and stem cells post-transplant can lead to long-term acceptance by altering the graft
Area of Science:
- Immunology
- Transplantation Biology
- Regenerative Medicine
Background:
- Liver transplantation is a life-saving treatment for end-stage liver disease.
- Chronic rejection and immunosuppression toxicity hinder wider application.
- Achieving transplant tolerance is a key goal in transplantation research.
Purpose of the Study:
- To investigate novel post-transplant strategies for achieving long-term liver allograft acceptance.
- To engineer graft repopulation in a stringent liver transplant model.
- To explore mechanisms of transplant tolerance induction.
Main Methods:
- Utilized a dark agouti (DA) to Lewis green fluorescent protein+ (LEW GFP+) rat strain combination for liver transplantation, a model prone to strong rejection.
- Employed a short-term post-transplant strategy involving low-dose immunosuppression and stem cell mobilization.
- Analyzed graft acceptance and donor-to-host phenotype transformation.
Main Results:
- Demonstrated long-term acceptance of liver allografts in a challenging rejection model.
- Identified two key mechanisms: transformation of the donor liver to a host self-phenotype and induction of specific allograft auto-suppression.
- Successfully engineered graft repopulation through immune modulation.
Conclusions:
- Purposeful manipulation of the immune response post-liver transplantation can induce long-term transplant acceptance.
- This strategy involves transforming the donor liver's phenotype to that of the host and inducing self-tolerance.
- These findings offer a promising alternative to chronic immunosuppression, advancing the goal of transplant tolerance.

